Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Turning Point Therapeutics, Inc. | EVP & Chief Scientific Officer | Common Stock | 17K | $1.29M | $76.00 | Feb 9, 2022 | Direct |
Turning Point Therapeutics, Inc. | EVP & Chief Scientific Officer | Stock Option (right to buy) | 48.8K | Feb 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TPTX | Turning Point Therapeutics, Inc. | Feb 9, 2022 | 3 | -$14.4K | 4 | Feb 11, 2022 | EVP & Chief Scientific Officer |